Drug intelligence / Profile preview

Golden Cells

Development stage
Preclinical
Lead developer
Stem Cell Institute
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Injection
01

Overview

Golden Cells is a proprietary allogeneic cell therapy developed by the Stem Cell Institute in Panama City, Panama. The treatment utilizes human umbilical cord tissue-derived mesenchymal stem cells (hUCT-MSCs) that are specifically selected from six unique cell lines identified through retrospective analysis of successful clinical outcomes. These cells are characterized by distinct molecular signatures that confer enhanced anti-inflammatory, immunomodulatory, and regenerative capabilities compared to standard mesenchymal stem cells. Golden Cells are used to treat a diverse range of conditions, including autism, multiple sclerosis, heart failure, and various autoimmune and orthopedic disorders, as well as for wellness and longevity applications. The cells are processed at the Medistem Panama laboratory and are typically administered via intravenous infusion or localized injection depending on the specific condition being treated.

Brand names
Golden Cells
Other names
hUCT-MSCshuman umbilical cord tissue-derived mesenchymal stem cells

Beyond the preview

Go deeper on Golden Cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golden Cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call